Interferon with novel characteristics produced by human mononuclear leukocytes

Area of Science:

• Immunology
• Virology
• Genetics

Background:

• Interferons (IFNs) are crucial cytokines in antiviral immunity.
• Previous research has identified various types of interferons with distinct properties.
• Understanding novel interferon subtypes is essential for advancing antiviral therapies.

Purpose of the Study:

• To investigate the production and characteristics of novel interferon-like substances.
• To determine the antiviral activity spectrum of the newly identified interferon.
• To compare the properties of the novel interferon with classical interferon types.

Main Methods:

• Treatment of human peripheral blood mononuclear leukocytes with phytohaemmaglutinin and teleocidin.
• Assay of interferon production.
• Antiviral activity testing across various human cell types, including trisomy-21 fibroblasts.
• Characterization of antigenic, biological, and physicochemical properties.

Main Results:

• Phytohaemmaglutinin and teleocidin induced significant production of interferon-gamma and a novel interferon-like substance, tentatively named interferon-delta.
• Interferon-delta demonstrated antiviral activity exclusively in trisomy-21 human fibroblasts among the tested cell types.
• The novel interferon-delta exhibited distinct antigenic, biological, and physicochemical properties compared to known interferon types.

Conclusions:

• A novel interferon, designated interferon-delta, is produced by human leukocytes under specific stimulation.
• Interferon-delta possesses unique antiviral properties, with specific activity in trisomy-21 fibroblasts.
• These findings highlight the diversity of interferons and suggest potential therapeutic implications for conditions like Down syndrome.